vs
IRIDEX CORP（IRIX）与TRANSACT TECHNOLOGIES INC（TACT）财务数据对比。点击上方公司名可切换其他公司
IRIDEX CORP的季度营收约是TRANSACT TECHNOLOGIES INC的1.3倍（$14.7M vs $11.5M），TRANSACT TECHNOLOGIES INC同比增速更快（11.9% vs -69.7%），过去两年IRIDEX CORP的营收复合增速更高（11.9% vs 3.5%）
IRIDEX Corporation是一家全球性医疗科技企业，主要研发、生产和销售面向眼科及医疗美容领域的激光类医疗设备，产品供应至北美、欧洲、亚太等地区的医疗机构与诊所，为眼部疾病治疗和医美项目提供微创解决方案。
该公司相关归属主体罗珀技术公司是一家控股集团，主要投资控股科技领域的各类企业，业务覆盖多个科技细分赛道，依托旗下子公司开展多元化科技业务布局。
IRIX vs TACT — 直观对比
营收规模更大
IRIX
是对方的1.3倍
$11.5M
营收增速更快
TACT
高出81.7%
-69.7%
两年增速更快
IRIX
近两年复合增速
3.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $14.7M | $11.5M |
| 净利润 | — | — |
| 毛利率 | 37.2% | 47.6% |
| 营业利润率 | — | -10.1% |
| 净利率 | — | — |
| 营收同比 | -69.7% | 11.9% |
| 净利润同比 | — | — |
| 每股收益（稀释后） | — | $-0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IRIXTACT
| Q4 25 | $14.7M | $11.5M | ||
| Q3 25 | $12.5M | $13.2M | ||
| Q2 25 | $13.6M | $13.8M | ||
| Q1 25 | $11.9M | $13.1M | ||
| Q4 24 | $12.7M | $10.2M | ||
| Q3 24 | $11.6M | $10.9M | ||
| Q2 24 | $12.6M | $11.6M | ||
| Q1 24 | $11.8M | $10.7M |
净利润IRIXTACT
| Q4 25 | — | — | ||
| Q3 25 | $-1.6M | $15.0K | ||
| Q2 25 | $-994.0K | $-143.0K | ||
| Q1 25 | $-1.7M | $19.0K | ||
| Q4 24 | $-834.0K | — | ||
| Q3 24 | $-1.9M | $-551.0K | ||
| Q2 24 | $-2.7M | $-319.0K | ||
| Q1 24 | $-3.5M | $-1.0M |
毛利率IRIXTACT
| Q4 25 | 37.2% | 47.6% | ||
| Q3 25 | 32.1% | 49.8% | ||
| Q2 25 | 34.5% | 48.2% | ||
| Q1 25 | 42.5% | 48.7% | ||
| Q4 24 | 44.0% | 44.2% | ||
| Q3 24 | 37.3% | 48.1% | ||
| Q2 24 | 40.7% | 52.7% | ||
| Q1 24 | 37.9% | 52.6% |
营业利润率IRIXTACT
| Q4 25 | — | -10.1% | ||
| Q3 25 | -11.3% | 0.1% | ||
| Q2 25 | -6.9% | -1.9% | ||
| Q1 25 | -1.7% | -0.1% | ||
| Q4 24 | -3.9% | -10.3% | ||
| Q3 24 | -16.1% | -7.7% | ||
| Q2 24 | -20.9% | -3.8% | ||
| Q1 24 | -28.0% | -12.2% |
净利率IRIXTACT
| Q4 25 | — | — | ||
| Q3 25 | -12.6% | 0.1% | ||
| Q2 25 | -7.3% | -1.0% | ||
| Q1 25 | -14.2% | 0.1% | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | -16.7% | -5.1% | ||
| Q2 24 | -21.2% | -2.8% | ||
| Q1 24 | -29.5% | -9.7% |
每股收益（稀释后）IRIXTACT
| Q4 25 | — | $-0.11 | ||
| Q3 25 | $-0.09 | $0.00 | ||
| Q2 25 | $-0.06 | $-0.01 | ||
| Q1 25 | $-0.10 | $0.00 | ||
| Q4 24 | $-0.05 | $-0.80 | ||
| Q3 24 | $-0.12 | $-0.06 | ||
| Q2 24 | $-0.16 | $-0.03 | ||
| Q1 24 | $-0.21 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.0M | $20.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $31.1M |
| 总资产 | $29.2M | $44.8M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资IRIXTACT
| Q4 25 | $6.0M | $20.4M | ||
| Q3 25 | $5.6M | $20.0M | ||
| Q2 25 | $6.8M | $17.7M | ||
| Q1 25 | $7.2M | $14.2M | ||
| Q4 24 | $2.4M | $14.4M | ||
| Q3 24 | $3.9M | $11.3M | ||
| Q2 24 | $4.1M | $11.1M | ||
| Q1 24 | $5.4M | $10.6M |
总债务IRIXTACT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $1.0M | — | ||
| Q3 24 | $1.4M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益IRIXTACT
| Q4 25 | — | $31.1M | ||
| Q3 25 | $4.7M | $31.8M | ||
| Q2 25 | $6.1M | $31.3M | ||
| Q1 25 | $852.0K | $30.9M | ||
| Q4 24 | $2.1M | $30.6M | ||
| Q3 24 | $2.6M | $38.4M | ||
| Q2 24 | $4.2M | $38.5M | ||
| Q1 24 | $6.5M | $38.6M |
总资产IRIXTACT
| Q4 25 | $29.2M | $44.8M | ||
| Q3 25 | $28.4M | $45.0M | ||
| Q2 25 | $31.6M | $44.5M | ||
| Q1 25 | $34.2M | $44.2M | ||
| Q4 24 | $29.1M | $44.0M | ||
| Q3 24 | $30.2M | $50.5M | ||
| Q2 24 | $31.2M | $50.4M | ||
| Q1 24 | $34.1M | $51.9M |
负债/权益比IRIXTACT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.48× | — | ||
| Q3 24 | 0.53× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $609.0K |
| 自由现金流经营现金流 - 资本支出 | — | $589.0K |
| 自由现金流率自由现金流/营收 | — | 5.1% |
| 资本支出强度资本支出/营收 | — | 0.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $7.6M |
8季度趋势，按日历期对齐
经营现金流IRIXTACT
| Q4 25 | — | $609.0K | ||
| Q3 25 | $-1.2M | $3.6M | ||
| Q2 25 | $-397.0K | $3.6M | ||
| Q1 25 | $-1.1M | $-161.0K | ||
| Q4 24 | $-1.2M | $2.4M | ||
| Q3 24 | $-3.1M | $327.0K | ||
| Q2 24 | $-1.3M | $636.0K | ||
| Q1 24 | $-1.6M | $-1.5M |
自由现金流IRIXTACT
| Q4 25 | — | $589.0K | ||
| Q3 25 | $-1.2M | $3.6M | ||
| Q2 25 | $-410.0K | $3.6M | ||
| Q1 25 | $-1.2M | $-171.0K | ||
| Q4 24 | $-1.2M | $2.4M | ||
| Q3 24 | $-3.1M | $259.0K | ||
| Q2 24 | — | $499.0K | ||
| Q1 24 | $-1.7M | $-1.6M |
自由现金流率IRIXTACT
| Q4 25 | — | 5.1% | ||
| Q3 25 | -9.4% | 27.1% | ||
| Q2 25 | -3.0% | 25.9% | ||
| Q1 25 | -9.8% | -1.3% | ||
| Q4 24 | -9.8% | 23.2% | ||
| Q3 24 | -26.5% | 2.4% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | -14.0% | -14.9% |
资本支出强度IRIXTACT
| Q4 25 | — | 0.2% | ||
| Q3 25 | 0.1% | 0.5% | ||
| Q2 25 | 0.1% | 0.1% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.1% | 0.1% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 1.2% | ||
| Q1 24 | 0.0% | 1.0% |
现金转化率IRIXTACT
| Q4 25 | — | — | ||
| Q3 25 | — | 242.00× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -8.47× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
